About Advanced Enzyme Technologies
Data last updated:
Advanced Enzyme Technologies is a company based in Thane (India) founded in 1989. The company has 693 employees. Advanced Enzyme Technologies has completed 3 acquisitions, including Evoxx Technologies, JC Biotech and SciTech. Advanced Enzyme Technologies offers products and services including Enzymes for Human Nutrition, Enzymes for Animal Nutrition, Enzymes for Food Processing, and Enzymes for Non-Food Processing. Advanced Enzyme Technologies operates in a competitive market with competitors including The DuPont Nutrition and Health, Enzymotec, Zivo Bioscience, Noblegen and Kaffe Bueno, among others.
- Headquarter Thane, India
- Employees 693
- Stage Public
- SectorsHealthcareConsumer
- EmailLocked
- PhoneLocked
- Website advancedenzymes.com
- Social LinkedIn
- Legal Name Advanced Enzyme Technologies Ltd
- Annual Revenue$79.4 M (USD)17.04as on Mar 31, 2026
- Net Profit$18.01 M (USD)28.68as on Mar 31, 2026
- EBITDA$24.73 M (USD)17.77as on Mar 31, 2026
- InvestorsAvendus
& 1 more
- Employee Count693
- Investments & AcquisitionsEvoxx Technologies
& 2 more
Associated legal entities of Advanced Enzyme Technologies
Advanced Enzyme Technologies is associated with 3 registered companies on The Company Check; the primary company is Advanced Enzyme Technologies Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity, and a full company report can be bought for any of them.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Report |
|---|---|---|---|---|---|---|---|
| Advanced Enzyme Technologies Limited Listed CIN L24200MH1989PLC051018 | Active | 15 Mar 1989 | Thane, Maharashtra | ₹670 Cr | 462 | 11 | Buy report |
| Advanced Vital Enzymes Private Limited CIN U24230MH2005PTC151389 | Active | 17 Feb 2005 | Thane, Maharashtra, India | $6.4M | – | – | Buy report |
| Advenza Global Limited CIN U24230MH2005PLC151389 | Active | 17 Feb 2005 | Thane, Maharashtra | ₹62.5 Cr | 189 | 11 | Buy report |
People of Advanced Enzyme Technologies
14 people are tracked at Advanced Enzyme Technologies (2 in leadership, 10 in board & advisors, 2 in team); the tracked headcount is 693.
| Name | Role | Group |
|---|---|---|
 Beni Prasad Rauka | Group CFO | Leadership |
B Rauka | CFO | Leadership |
| Director | Board & advisors | |
 Rajshree Patel | Director | Board & advisors |
 Kedar Jagdish Desai | Director | Board & advisors |
 Ms. Rasika Rathi | Director | Board & advisors |
 Vinod Jajoo | Director | Board & advisors |
 V. L. Rathi | Chairman | Board & advisors |
| Director | Board & advisors | |
| Director | Board & advisors | |
 Rajesh Sharma | Director | Board & advisors |
| Director | Board & advisors | |
Vivek Shah | Senior Manager - Accounts And Finance | Team |
 Ronak Saraf | Investor Relations & ESG Manager | Team |
Complete people profiles for Advanced Enzyme Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Board of directors of Advanced Enzyme Technologies Limited (Advanced Enzyme Technologies)
Advanced Enzyme Technologies Limited is the primary company behind Advanced Enzyme Technologies. The boards of the 2 registered companies of Advanced Enzyme Technologies currently have 18 directors; the longest-serving is Vasant Rathi, appointed in 1993. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vasant Rathi DIN 01233447 | Director | 05 Mar 1993 | 33 yrs 7 mo | Advanced Enzyme Technologies Limited |
| Mukund Madhusudan Kabra DIN 00148294 | Whole-time director | 04 Sep 1999 | 27 yrs 1 mo | Advanced Enzyme Technologies Limited |
| Savita Chandrakumar Rathi DIN 00365717 | Director | 17 Feb 2005 | 21 yrs 7 mo | Advenza Global Limited |
| Chandrakumar Laxminarayan Rathi DIN 00365691 | Director | 17 Feb 2005 | 21 yrs 7 mo | Advenza Global Limited |
| Piyush Chandrakumar Rathi DIN 00366347 | Managing Director | 17 Feb 2005 | 21 yrs 7 mo | Advenza Global Limited |
| Radhika Pujara Ashish DIN 00984733 | Director | 14 Sep 2015 | 11 yrs | Advenza Global Limited |
| Divya Piyush Rathi DIN 07244598 | Director | 14 Sep 2015 | 11 yrs | Advenza Global Limited |
| Pramod Kasat DIN 00819790 | Director | 14 Dec 2016 | 9 yrs 9 mo | Advanced Enzyme Technologies Limited |
| Rasika Vasant Rathi DIN 08300682 | Director | 08 Jan 2019 | 7 yrs 9 mo | Advanced Enzyme Technologies Limited |
| Vinodkumar Hiralal Jajoo DIN 08224980 | Director | 09 Feb 2019 | 7 yrs 7 mo | Advanced Enzyme Technologies Limited |
| Sunny Sharma DIN 02267273 | Director | 02 Nov 2019 | 6 yrs 11 mo | Advanced Enzyme Technologies Limited |
| Nitin Jagannath Deshmukh DIN 00060743 | Director | 01 Jul 2022 | 4 yrs 3 mo | Advanced Enzyme Technologies Limited |
| Vandana Ravindra Tilak DIN 10048021 | Director | 01 Jul 2023 | 3 yrs 3 mo | Advanced Enzyme Technologies Limited |
| Bhavna Jain DIN 10700176 | Company Secretary | 23 Jun 2025 | 1 yr 3 mo | Advenza Global Limited |
| Jayesh Narendra Sheth DIN 03506031 | Director | 08 Aug 2025 | 1 yr 2 mo | Advenza Global Limited |
| Ashish Mulchand Gala DIN 06436575 | Director | 08 Aug 2025 | 1 yr 2 mo | Advenza Global Limited |
| Nikhil Jugalkishor Kalantri DIN 10036710 | CFO | 08 Aug 2025 | 1 yr 2 mo | Advenza Global Limited |
| Pradip Bhailal Shah DIN 01225582 | Additional Director | 12 Jun 2026 | 3 mo | Advanced Enzyme Technologies Limited |
IPO & Listings of Advanced Enzyme Technologies
Advanced Enzyme Technologies is a publicly listed company on the NSE with ticker symbol ADVENZYMES in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Advanced Enzyme Technologies
Advanced Enzyme Technologies offers a comprehensive portfolio of products and services, including Enzymes for Human Nutrition, Enzymes for Animal Nutrition, Enzymes for Food Processing, and Enzymes for Non-Food Processing.
Enzymes for pharmaceutical and nutraceutical formulations to enhance nutrition
Improves digestibility of feed components for better animal health
Used in food and beverages to boost nutrition and appeal
Provides solutions for textiles, leather, and paper processing
Financials of Advanced Enzyme Technologies
Figures of Advanced Enzyme Technologies Limited, the primary company behind Advanced Enzyme Technologies, for FY 2025. Revenue was ₹670 Cr (+1% year on year). Net profit was ₹134 Cr (20% margin). EBITDA was ₹227 Cr (34% margin).
- ₹670 CrRevenue · FY 2025 · +1% YoY
- ₹134 CrNet profit · 20% margin
- ₹227 CrEBITDA · 34% margin
- ₹22.39 CrPaid-up capital
- 462Employees (provident fund records)
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹745 Cr | ₹169 Cr | ₹232 Cr |
| 2024 | ₹637 Cr | ₹131 Cr | ₹197 Cr |
| 2023 | ₹623 Cr | ₹133 Cr | ₹207 Cr |
| 2022 | ₹540 Cr | ₹106 Cr | ₹165 Cr |
| 2021 | ₹529 Cr | ₹120 Cr | ₹206 Cr |
Balance sheet, profit and loss, cash flow and ratios of Advanced Enzyme Technologies Limited are on its company page.
Buy the company report of Advanced Enzyme Technologies LimitedDetailed financial statements for Advanced Enzyme Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Funding Insights of Advanced Enzyme Technologies
- Total Rounds 2
- First Round $16.1M
(07 May 2018)
- Investors Count 2
All 2 funding rounds of Advanced Enzyme Technologies with amounts, post-money valuations and investors.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| 01 Sep 2020 | Undisclosed | Post-IPO | – | – | |
| 07 May 2018 | $16.1M | Debt – Conventional | – | – |
Current stage: Public. 2 investors in total: 2 institutional.
Investors in Advanced Enzyme Technologies
Advanced Enzyme Technologies has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Avendus and Nalanda Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in exceptional businesses within Indian public markets, focusing on small to mid-cap companies. | 2007 | nalandacapital.com | - | |
Corporate advisory and investment services are provided to clients. | 1999 | avendus.com | Mumbai, India |
Investor details for Advanced Enzyme Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Advanced Enzyme Technologies
Advanced Enzyme Technologies has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Evoxx Technologies, JC Biotech and SciTech.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Contract manufacturing of industrial goods is handled by SciTech. | scitech.net.in | Mumbai, India | 2007 | Dec 2020 | $4.3M | |
Enzymes and bio-catalytic processes are developed for industrial applications. | evoxx.com | – | 2006 | Jul 2017 | $8.9M | |
Nutraceuticals, biopharmaceuticals, and bio-chemicals are manufactured for API synthesis. | jcbiotech.com | Hyderabad, India | 2004 | Oct 2016 | $7.5M |
Complete acquisition details for Advanced Enzyme Technologies
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Advanced Enzyme Technologies
7 dated milestones of Advanced Enzyme Technologies across 31 years, from founding to its latest funding, stage changes and deals.
- Advanced Enzyme Technologies is founded.
- Lists on the stock exchange (IPO).
- Acquires JC Biotech.
- Acquires Evoxx Technologies.
- First funding round of $16.1M.
- Latest funding round, Post-IPO,.
- Acquires SciTech.
Competitors of Advanced Enzyme Technologies
Advanced Enzyme Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as The DuPont Nutrition and Health, Enzymotec, Zivo Bioscience, Noblegen and Kaffe Bueno, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| danisco.com | 1989 | Copenhagen, Denmark | $880,085 | 1,007 | Manufactures a range of health ingredients | |
| enzymotec.com | 1998 | Kfar Saba, Israel | $21.0M | – | Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses. | |
| zivobioscience.com | 1983 | Keego Harbor, United States | $962,000 | 10 | Bioactive compounds from algal strain | |
| noblegen.com | 2013 | Peterborough, Canada | $18.5M | – | Naturally-derived ingredients from microorganisms are developed for human nutrition. | |
| kaffebueno.com | 2016 | Copenhagen, Denmark | $8.1M | – | Coffee beans are supplied by Kaffe Bueno in multiple categories. | |
| terravia.com | 2003 | San Francisco, United States | $60.0M | – | Algae-based specialty ingredients are manufactured and supplied for food applications. | |
| zarbees.com | 2008 | Draper, United States | $28.3M | – | Natural cough remedies and wellness products are developed by Zarbees. |
Detailed competitors of Advanced Enzyme Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Advanced Enzyme Technologies
Complete news archive for Advanced Enzyme Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Advanced Enzyme Technologies
Advanced Enzyme Technologies was founded in 1989 and raised its 1st funding round 29 years after it was founded.
Advanced Enzyme Technologies is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Advanced Enzyme Technologies has 693 employees.
Annual revenue of Advanced Enzyme Technologies is $79.4M as on Mar 31, 2026.
Advanced Enzyme Technologies was founded in 1989 and is headquartered in Thane, India. Enzymes are developed through microbial research and produced at commercial scale for sectors including human nutrition, food processing, animal feed, and non-food applications such as textiles and leather. Customized enzyme solutions and formulations are provided, covering probiotics, animal nutrition, and various other uses.
Advanced Enzyme Technologies's top competitors include Zivo Bioscience, Enzymotec and The DuPont Nutrition and Health.
Advanced Enzyme Technologies offers Enzymes for Human Nutrition, Enzymes for Animal Nutrition, Enzymes for Food Processing, and Enzymes for Non-Food Processing.
Yes, Advanced Enzyme Technologies is publicly traded on NSE under the ticker symbol ADVENZYMES.
Advanced Enzyme Technologies has made 3 acquisitions, including Evoxx Technologies, JC Biotech, and SciTech.
Advanced Enzyme Technologies has 2 investors. Key investors include Avendus, and Nalanda Capital.
The ticker symbol of Advanced Enzyme Technologies is ADVENZYMES on NSE.
Advanced Enzyme Technologies is associated with 2 legal entities: Advanced Vital Enzymes Private Limited, Advanced Enzyme Technologies Limite.
Advanced Enzyme Technologies is classified as a public.
The legal entities of Advanced Enzyme Technologies currently have 20 directors, including Mukund Madhusudan Kabra, Vinodkumar Hiralal Jajoo, Rasika Vasant Rathi and others.